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Abstract: Esophagitis denotes a localized or diffuse inflammation of the esophageal mucosa. It is gen-
erally thought to result from a caustic or chemical (ie, gastric acid, bile acids) injury. In humans, the
most frequent mechanism causing esophagitis is gastroesophageal reflux (GER) leading to GER disease
(GERD). GERD is thought to result from lower esophageal sphincter (LES) incompetence. In small
animal medicine, GERD secondary to a primary functional LES abnormality is poorly understood, most
probably because diagnosing GERD based on a detailed questionnaire on perceived symptoms, as it is
done in human medicine, is not applicable. The situation becomes even more complicated when consid-
ering that the nonerosive form of GERD (ie,absence of visible lesions on esophagoscopy and the presence
of reflux-associated symptoms) comprises the majo rity of patients in human medicine.
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INTRODUCTION
Esophagitis denotes a localized or diffuse inflammation of the esophageal mucosa. It
is generally thought to result from a caustic or chemical (ie, gastric acid, bile acids)
injury. In humans, the most frequent mechanism causing esophagitis is gastroesoph-
ageal reflux (GER) leading to GER disease (GERD). GERD is thought to result from
lower esophageal sphincter (LES) incompetence.1 In small animal medicine, GERD
secondary to a primary functional LES abnormality is poorly understood, most prob-
ably because diagnosing GERD based on a detailed questionnaire on perceived
symptoms, as it is done in human medicine, is not applicable. The situation becomes
even more complicated when considering that the nonerosive form of GERD (ie,
absence of visible lesions on esophagoscopy and the presence of reflux-associated
symptoms) comprises the majority of patients in human medicine.1
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KEY POINTS
 Esophagitis is mostly a consequence of increased exposure to gastroduodenal reflux
owing to various primary causes.
 An exception is eosinophilic esophagitis, an emerging primary inflammatory disease of the
esophagus with a presumed allergic etiology.
 Clinical signs can vary and it can be difficult to differentiate esophagitis from other upper
(mostly food-responsive) gastrointestinal diseases.
 When no extraesophageal disease can explain clinical signs, gastroesophageal reflux dis-
ease owing to an incompetent lower esophageal sphincter, similar to the well-known con-
dition in people, is suspected.
 Esophagitis owing to gastroesophageal reflux can be confirmed with wireless esophageal
pH-monitoring (Bravo capsule), endoscopy, or esophageal endoscopic biopsies and
histology.
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It should also be noted in this context that, independent of the cause of esophagitis,
esophageal inflammation in itself can cause esophageal hypomotility and thus gastro-
esophageal sphincter weakness by impairing the excitatory cholinergic pathways to
the gastroesophageal sphincter. In cats, induction of experimental esophagitis has
been shown to attenuate the release of acetylcholine and lowered gastroesophageal
pressures. These changes were reversible on healing of the esophagus.2,3
CONDITIONS ASSOCIATED WITH ESOPHAGITIS
Esophagitis is for the most part not an independent disease in cats and dogs, but de-
velops secondary to gastro(duodenal) reflux, which in turn can have various causes.
The most common scenario for esophagitis in cats and dogs is perianesthetic reflux.
Clinical signs usually begin a couple of days after anesthesia, and the diagnosis is usu-
ally based on a combination of medical history and ensuing clinical signs. It has been
reported that intraabdominal procedures have a higher risk for GER, also the duration
of preoperative fasting and choice of preanesthetic drugs influence the incidence of
GER during anesthesia.4–7 In extreme cases, lethal esophageal rupture secondary
to perianesthetic acid reflux is possible8; however no information exists on associa-
tions between magnitude of intraoperative esophageal acid exposure and the risk of
subsequent esophageal inflammation. Further causes are medication-induced cases
of esophagitis. Cats seem to be particularly susceptible to pill-induced esophagitis
when receiving peroral medication, and antibiotics such as clindamycin and doxycy-
cline (doxycycline hyclate is known to cause a strong acidic solution [pH 2–3]
compared with doxycycline monohydrate) have been frequently implicated.9,10
Thus, the routine administration of a small water bolus to facilitate esophageal clear-
ance is recommended in this species.11 Further causes are lodged foreign bodies,
frequent vomiting, malpositioned esophageal feeding tubes, and distal esophageal
neoplasia (often leiomyoma),12,13 all of which permit increased exposure of the esoph-
ageal mucosa to gastro(duodenal) reflux. Primary gastric hyperacidity conditions such
as Zollinger–Ellison syndrome14,15 or delayed gastric emptying owing to acute pancre-
atitis or pyloric outflow obstructions can also lead to esophagitis when refluxing
gastric contents injure the esophageal mucosa. Hiatal hernias also predispose to
esophagitis in dogs and cats because of the altered functional anatomy of the gastro-
esophageal pressure barrier (loss of the intrinsic support of the crural diaphragm) and
impaired esophageal acid (Video 1).16–18 Hiatal hernias and associated GER resulting
from upper airway obstruction are common problems in brachycephalic dog
breeds.19–21 Less commonly, non–breed-specific upper airway obstruction may also
cause reflux esophagitis.22,23 The supposed pathomechanism is the negative intratho-
racic pressure generated by increased inspiratory effort. Yeast esophagitis (Candida
spp) can rarely develop as a secondary complication in cases of idiopathic megaeso-
phagus owing to the chronic effects of lodging food.
Probably the only primary inflammatory esophageal disease without an underlying
condition predisposing to GER is eosinophilic esophagitis (EE). This entity is a recently
recognized inflammatory disorder of the esophagus in dogs and cats suspected to be
a hypersensitivity disorder that results in marked accumulation of eosinophils within
the esophageal tissue.24,25 Eosinophil presence and activity then results in tissue
damage, edema, inflammation, and fibrosis. Only case reports have been reported
up to now and it is currently unclear whether EE is underdiagnosed in cats and dogs.
Reflux esophagitis owing to a LES incompetence similar to GERD in humans is also
frequently suspected in dogs and cats based on a variety of clinical signs assumed to
reflect esophageal pain. Specific diagnostic criteria for GERD are lacking and a
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tentative diagnosis is made based on clinical and endoscopic findings, exclusion of
other esophageal and extraesophageal diseases, and an adequate response to treat-
ment.18,26–29 The crux is that diagnosing GERD in people is largely based on symptom
perception, and ideally a close correlation between reflux and symptom during ambu-
latory esophageal pH-metry.1 However, although symptoms are by definition inher-
ently subjective experiences and communicated to the health care professional by
the human patient, cats and dogs naturally exhibit clinical signs that can or cannot
reflect sensations associated with esophagitis. This is why GERD is mostly a diagnosis
of exclusion in our patients and ideally based on a clear response to treatment.
Recently, the 3-year incidence of suspected canine GERD presented to a specialty
practice was estimated at 0.9%, diagnoses have been based on a combination of his-
torical and clinical signs, as well as radiographic, endoscopic, or histopathologic find-
ings without actual demonstration of increased esophageal reflux events.29 It is still
controversial if GERD is truly an independent disease in cats and dogs, because in-
flammatory small bowel disease can present with similar clinical signs.28,30 In the au-
thors’ experience, many patients with clinical signs originally attributed to reflux
esophagitis have chronic inflammatory enteropathies and can in fact be successfully
managed in the long term with dietary changes, high-dose multistrain probiotics or
budesonide.
Cats with chronic gingivostomatitis have recently been shown to have a high inci-
dence of concurrent esophagitis based on endoscopy and histology.31 It remains diffi-
cult to determine to what extent esophageal inflammation causes clinical signs in
these patients as clinical features are limited and cannot distinguish with certainty sto-
matitis from esophagitis. Dogs with idiopathic laryngeal paralysis can also have
increased acidic reflux events compared with clinically normal dogs with refluxes
even reaching the most proximal part of the esophagus.32 However, these findings
were not accompanied by endoscopic evidence of esophagitis and esophageal bi-
opsies were not collected in that study.
CLINICAL SIGNS
Esophagitis may lead to immediate signs caused by inflammation or delayed signs
caused by stricture formation. Animals with mild esophagitis may show no clinical
signs, whereas animals with more severe esophagitis can show decreased appetite,
anorexia, odynophagia or dysphagia, ptyalism, increased empty swallowing motions,
extension of head and neck while swallowing, retching, vomiting, regurgitation, sud-
den unexplained discomfort, belching, drooling, excessive grass eating, or surface
licking. Brachycephalic breeds (especially French Bulldogs) usually show a mixture
of regurgitation and retching of frothy material mostly during increased activity or
excitement.
Clinical signs reported in the literature include retching, gagging, repeated swallow-
ing motions, smacking, discomfort at night, sudden nervousness, restlessness or
discomfort, and refusal to eat despite apparent interest in food.18,24–26,28,29
Pruritus and other manifestations of allergic skin disease may be seen in cases of
EE. Concurrent borborygmi may indicate that it is a small bowel disease after all,
even in the absence of diarrhea. Although it would seem to be plausible that the
severity of clinical signs depends on the extent and depth of esophageal lesions,
they do not always correlate and may vary greatly. Hoarseness, stridor, and cough
could reflect injury to the epiglottis, larynx, and upper airway.30 The onset of
anesthesia-associated reflux esophagitis varies from 1 to 3 days to 2 weeks after a
causative anesthetic event.33,34 On physical examination, patients may have evidence
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of halitosis and laryngeal signs with redness, hyperemia, and edema of the vocal folds
and arytenoids. However, the majority of patients have normal physical examinations.
Clinical signs of strictures depend on the degree of obstruction; the narrower the stric-
ture the more pronounced is the regurgitation; however, regurgitation also could be
caused by painful swallowing. Strictures closer to the pharynx may cause more imme-
diate regurgitation. Mild to moderate strictures may cause no clinical signs until the
patient swallows a large food bolus or firm food (Fig. 1A, B). Sometimes there is
gradual progression in severity as the stricture continues to contract, causing greater
luminal narrowing.
Care should be taken to evaluate the respiratory system as, analogous to humans, it
is surmised that esophagitis can also cause inflammatory airway disease. Pulmonary
manifestations of esophagitis may include aspiration pneumonia, chronic bronchitis,
and potentially interstitial pulmonary fibrosis. Concerning this aspect, it is of particular
interest to note that idiopathic pulmonary fibrosis is seen nearly exclusively in older
West Highland White Terriers, a breed that is at the same time notoriously famous
for lodged esophageal foreign bodies.35–37 Chronic intermittent microaspiration of
gastric acid secondary to an esophageal dysmotility may be a contributing causative
event in this breed. A recent study found that, although gastric juice microaspirations
occurred in various canine respiratory diseases, bile acids measured in bronchoalveo-
lar lavage fluid as a surrogate marker for microaspirations of gastroduodenal content
were detected only in healthy West Highland White Terriers.38
DIAGNOSIS
Diagnostic Imaging
Although historical and clinical findings may be suggestive of esophagitis, the results
of routine laboratory testing are usually normal. Radiography is of limited use for the
detection of esophagitis; compatible findings may bemild esophageal dilations or fluid
Fig. 1. (A) Partial midthoracic esophageal stricture in an 8-year-old King Charles Cavalier
Spaniel with esophagitis secondary to a lodged foreign body (chewing bone) that had
been sitting in the esophagus for 2 days. The dog started to regurgitate again 5 days after
removal of the foreign body when fed a regular amount. Small portion were well-tolerated.
(B) Distal esophagus of the same dog with multiple brownish dots representing a prolifer-
ative response of submucosal glands to increased acidic reflux.
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accumulation in the distal esophagus. However, foreign bodies, hiatal hernias, esoph-
ageal dilation, ring anomalies, or masses could be detected and a pathologic lung
pattern may reflect aspiration injury to the lungs. Mediastinal or pleural air or liquid
accumulation may indicate esophageal perforation. If a perforation is considered
likely, an iodinated contrast medium should be used instead of barium. Although
contrast esophagrams are inexpensive, readily available, and noninvasive tests,
they are only useful in demonstrating stenotic narrowing or intramural masses of the
esophagus. The sensitivity of barium esophagram to detect esophagitis is low.
Mucosal irregularities and a prolonged retention of the contrast medium can be
seen with moderate to severe inflammation, whereas milder forms of esophagitis
will be missed.4 Fluoroscopic swallow studies have the benefit to assess esophageal
motility during the whole swallow with less of a chance to miss the moment, when the
contrast medium passes a narrow point, as could be the case with static images. It is
of importance to do wet swallows with liquid contrast medium and dry swallows with a
barium–food mixed bolus, because liquids can sometimes pass a partial stricture,
whereas a food bolus may be retained. Although swallow studies can assess causes
(reflux episodes, hiatal hernia [see Video 1], mural masses) as well as consequences
(dysmotility, strictures, reflux episodes) of esophagitis, it is not a useful modality to di-
agnose esophagitis.
ENDOSCOPY
Endoscopic examination is the most sensitive method to diagnose esophagitis,
although reliable endoscopic criteria for diagnosis of esophagitis as well as grading
of severity of esophagitis have not been established in small animals. Of note, no
descriptive endoscopic work larger than case reports has been published on canine
or feline esophagitis, and it is likely that subtle lesions go undetected. Only 1 in 22
dogs presenting with clinical signs attributed to esophagitis also had endoscopic ev-
idence of esophagitis in a recent study.28 Early signs of esophagitis are erythema and
edema usually above the LES (Fig. 2), but these findings depend on the quality of
endoscopic equipment. Other signs include increased vascularity, because enlarged
capillaries develop in response to acid near the mucosal surface (Fig. 3A, B). Pro-
longed acidic injury leads to proliferation of submucosal esophageal glands in
dogs,39 and their excretory ducts can readily be seen as round dots (Fig. 4). Another
common sign is increased granularity; the mucosal surface seems to be rough and
puckered (Fig. 5). Findings compatible with severe esophagitis are areas of exudative
pseudomembranes and ulcerative mucosa. The esophageal mucosa of published
cases of EE of cats and dogs seems to be clearly abnormal with marked proliferative
mucosal lesions similar to a cobblestone appearance, friable and hyperemic mucosa
with exudative and ulcerated mucosa, and the presence of benign structure forma-
tion.24,25 Typical gross endoscopic findings in humans with EE comprise concentric
rings, furrows, exudate, and strictures. However, a normal endoscopic examination
has been reported in up to 40% of cases and EE can be missed without biopsies.40
This author has been actively looking for EE in esophageal biopsies from patients
with compatible clinical signs and unremarkable esophageal linings, but has not found
a case as of yet. Although typical for reflux esophagitis, circular inflammation just
above the LES should not be confused with the squamocolumnar junction (the demar-
cation line between the squamous esophageal lining and the columnar gastric lining,
the so-called z-line), that may seem to be sharply delineated in cats and dogs with
erythematous and reddened gastric mucosa. This is especially the case with esoph-
ageal overinsufflation. Strictures are usually obvious at endoscopy; exceptions could
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be large breeds with esophageal diameters much bigger than the scope where stric-
tures could be missed. In these cases, generous air insufflation will usually help to
demonstrate the focally reduced esophageal diameter. The endoscopic examination
should always include a full gastric inspection with special attention to the cardia
and pylorus to exclude underlying abnormality, such as obstructive leiomyoma or
radiolucent foreign bodies, to confirm that the esophagitis is the primary problem.
Concurrent duodenoscopy and biopsies seems reasonable given the unspecific clin-
ical signs that could also reflect the presence of small bowel disease.
Narrow band imaging uses only blue and green light that is absorbed by vessels but
reflected by mucosa, and can better capture the microstructures of the superficial mu-
cosa and reveal subtle changes of patients with esophagitis in human medicine.41 The
value of narrow band imaging has still to be determined in canine and feline esopha-
gitis (Fig. 6).
ESOPHAGEAL HISTOLOGY
It could be argued that esophagoscopy without biopsy is insufficient to rule out esoph-
agitis, because cases with grossly normal appearing mucosa on endoscopy and nec-
ropsy, but histopathologic evidence of esophagitis, have been reported in cats and
dogs.12,26,31,42,43 This finding is in accordance with findings in humans, where endo-
scopic findings in patients with GERD vary from no visible mucosal damage (termed
nonerosive esophageal reflux disease) to esophagitis, peptic strictures, or Barrett’s
esophagus.1 Unfortunately, it can be difficult to obtain adequate esophageal biopsies,
except in the more severe cases of esophagitis, because the esophagus is lined with a
robust stratified squamous epithelium, and even repeated biopsies with serrated for-
ceps from the same location may yield only epithelial bits. Münster and colleagues44,45
advocate taking biopsies from the gastroesophageal junction using standard forceps
Fig. 2. Distal esophagitis in a 1-year-old male French Bulldog presenting for daily regurgita-
tion. Streaky erosions can be seen just above the LES (arrows). Final diagnosis was reflux
owing to brachycephalic obstructive airway syndrome.
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Fig. 3. (A) Distal esophagitis just above the LES in a 6-year-old female spayed Bernese Moun-
taindog presented for inappetence. No cause could be identified. (B) Esophagoscopy of a 9-
year-old Labrador Retriever presented for increased lip smacking and empty swallowing.
There is circumferential increased vascularity around the LES beginning at the Z-line (white
arrow). Gastroscopy (C) of the dog under 3B revealed increased granularity, erythema, and
protruding bulges. Histopathology revealed severe lymphocytic gastritis with fibrosis, a dif-
ferential diagnosis was small cell lymphoma.
Fig. 4. (A) Same dog as in Fig. 3B and C. Prolonged acidic injury leads to proliferation of sub-
mucosal esophageal glands and their excretory ducts can be seen as round brown spots. (B)
Narrow band imaging.
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Fig. 5. Distal esophagus of an 18-month-old male neutered Maine Coon cat 14 months after
surgical correction (Y-U cardioplasty) and subsequent ballooning of a congenital esophageal
stenosis. The cat could eat again and thrived to a normal sized clinically healthy Maine Coon
cat. A side effect of the surgery was incomplete closure of the LES, and twice daily omepra-
zole was prescribed. The esophageal mucosa seems to be edematous, with patchy erythema
and increased granularity, the typical ringed structure of the feline esophagus is only
partially visible.
Fig. 6. LES of an 8-year-old male Jack Russel Terrier with intermittent vomiting, lip smacking,
and refusal to eat. White light endoscopy (A) shows mild mucosal vein dilation (thin arrows)
and discrete longitudinal stripes (thick arrows) reflecting activated excretory ducts of sub-
mucosal glands. (B) Narrow band imaging (blue green endoscopy) accentuates these find-
ings. Wireless esophageal pH-monitoring revealed a fractional time pH less than 4 of 1%
(0%–3.1%). Histopathology revealed moderate gastric and duodenal lymphoplasmacytic
inflammation. No improvement was seen with gastric acid suppression, and clinical signs
finally disappeared with a novel protein diet and budesonide.
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for single use with open elliptical branches, and a lancet. Structural microscopic ab-
normalities such as fibrosis, inflammation, elongation of the stromal papillae, and
increased thickness of the basal cell layers can be found in biopsies comprising
only the squamous epithelium and the lamina propria mucosae.27,29 Before the advent
of esophageal pH-metry, esophageal histology was used in the research on GERD in
people, and hyperplastic thickening of the basal cell layer and abnormal elongation of
stromal papillae of the lamina propria were found to reflect excessive regeneration and
thus were considered pathognomonic for GERD in humans.46,47 Histologic evidence
of hyper-regeneratory changes in esophageal biopsies was recently also reported in
20 dogs presenting with clinical signs suggestive of reflux esophagitis (Fig. 7).29 So
far, the sensitivity of these histologic lesions for the diagnosis reflux esophagitis has
not been evaluated against a quantifiable gold standard, such as intraesophageal
pH-metry, but the predominant clinical signs regurgitation and ptyalism improved in
8 of 11 dogs with hyper-regeneratory esophagopathy after treatment with proton
pump inhibitors.29 The specificity of esophageal histologic lesions has not been
assessed so far, and this endeavor seems to be challenging because clinically silent
reflux esophagitis cannot be ruled out with certainty. But still, hyper-regeneratory
esophageal lesions were significantly less common in age-matched control dogs
(n 5 19) undergoing endoscopy for clinical signs unrelated to the esophagus (eg,
chronic diarrhea).29 Clearly, further work is necessary to clarify the prevalence and
thus significance of esophageal histologic lesions of cats and dogs. Endoscopic find-
ings of severe chronic acid exposure such as Barrett’s esophagus (replacement of the
normal squamous epithelium of the distal esophagus with metaplastic columnar
epithelium) are exceedingly rare in cats and dogs, further illustrating that GERD might
not be as common as in humans.18,48
In contrast, the histologic findings of EE seem to be straightforward; eosinophils are
not found in the healthy esophagus, making the presence of these cells indicative of
disease. Guidelines in humans recommend that a diagnosis of EE is made when a pa-
tient presents with symptoms of esophageal dysfunction and esophageal biopsies
demonstrate 15 or more eosinophils in a high power field in the absence of competing
Fig. 7. pH capsule attached to the distal esophageal mucosa for continuous esophageal pH
monitoring in a dog with suspicion of reflux esophagitis.
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causes such as GERD.49 Reported eosinophil counts in mucosal biopsies of cats and
dogs with EE ranged from 20 to 40 eosinophils per high power field.24,25
ESOPHAGEAL pH-METRY
All these procedures may aid in the diagnosis of esophagitis, but still fail to detect and
quantify reflux when GERD is suspected. In humans, catheter-free esophageal pH
monitoring has become the gold standard in diagnosing GERD. This technique not
only provides information on esophageal acid exposure, but is also able to assess
symptoms associated with acid reflux episodes. A widely used system in humans is
the Bravo system. It includes a small capsule (26.0 mm  5.5 mm  6.5 mm) contain-
ing an antimony pH electrode with internal reference, miniaturized electronics with
radiofrequency transmitter and battery, and a capsule delivery system, as well as
an external receiver to monitor intraesophageal pH. This wireless pH monitoring sys-
tem was found to be a useful tool for extended (generally 4 days; some capsules
adhere up to 7 days to the mucosa and esophageal pHmeasurement can be extended
accordingly) ambulatory catheterless esophageal pH monitoring in dogs.28 Endo-
scopic capsule placement was quick and easy, and adverse clinical signs have not
been observed.28 Current disadvantages of the system are the high cost of the pH
capsule, receiver, and software, as well as the need for brief anesthesia for accurate
placement. Our clinical experience indicates that this technique seems to be safe and
patients from 6 to 55 kg body weight tolerate the measurements well. The capsule is
positioned in the distal esophagus 3 to 5 cm above the LES and attached (ie, pierced)
to the mucosa (see Fig. 7). Mucosal attachment is achieved by the use of vacuum suc-
tion and a lock and pin mechanism. Once released from the delivery system, pH data
are recorded by a receiver attached to the dog’s collar and owners are instructed to
maintain a logbook to record all events presumed to be related to GER. The receiver
has so-called symptom buttons that can be individually programmed. At discharge,
owners are familiarized with the receiver and instructed to press the appropriate but-
tons if the dog shows the corresponding clinical signs. An association between clinical
signs and reflux is considered positive if the clinical signs occurs within 1 to 2 minutes
of the reflux event. In people, the so-called symptom index is defined as the percent-
age of symptom events that are temporally related to a reflux episode. A symptom in-
dex of 50% usually is considered positive.50
Our results contradicted the hypothesis that minute amounts of acid can severely
damage the esophagus in dogs. In healthy dogs, the number of refluxes (defined as
an esophageal pH of <4) and the duration of long refluxes (>5 minutes) varied consid-
erably over the course of 96 hours. The median total number of refluxes was 10 (range,
1–65), the median number of refluxes lasting longer than 5 minutes was 1 (range, 0–4),
the median duration of longest reflux was 8 minutes (range, 0–27). The overall fraction
time of a pH of less than 4 was low and usually ranged between 0% and 3%.28 These
numbers are actually lower compared with what has been established as normal in
humans (4.0%–6.7%).51,52 Results in dogs with clinical signs commonly attributed
to reflux esophagitis were insofar surprising as clinically relevant reflux episodes could
not be demonstrated in 17 of 22 suspected dogs and a temporal relationship between
clinical signs observed by owners and reflux episodes could also not be established.
Still, dogs with clinical signs had overall higher esophageal pH parameters when
compared with healthy dogs.28 A clear limitation of the study was that esophageal
pH recordings were available from only 7 healthy control dogs and therefore no robust
reference range exists for comparison of esophageal pH data at this point. Another
conclusion from that study was that the differential diagnosis diet-responsive
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enteropathy should be ruled out as best as possible before pursuing treatment for
esophagitis, because both diseases can have similar clinical signs.28 Since that study,
we have used this system frequently in dogs with clinical signs suggestive of esoph-
agitis, but could detect abnormal esophageal pH profiles in only a handful of dogs. In
fact, complete resolution of clinical signs is rarely achieved with gastric acid suppres-
sion alone,30 and most dogs ultimately respond to dietary changes, probiotics, and
less commonly budesonide.
THERAPY
Treatment should ideally be directed at the underlying causes of the esophagitis and it
is important to eliminate predisposing factors (eg, oral medication). In case of a
chronic obstructive upper respiratory problem, corrective surgery minimizing or elim-
inating the obstruction may also resolve inflammatory esophageal lesions.19 The same
would apply to hiatal hernias. Because anesthesia is the most common cause of
esophagitis, it would be desirable to prevent acidic reflux in patients undergoing anes-
thesia, especially in those that already have a history of anesthesia-related esophagi-
tis. Pretreatment with high doses of metoclopramide yielded conflicting results and
the administration of ranitidine before surgery also did not reduce the incidence of
GER.53,54 Although preanesthetic administration of cisapride and esomeprazole
together decreased the number of reflux episodes in anesthetized dogs in a recent
study, the administration of esomeprazole alone was felt to be less effective because
it only decreased the acidity of refluxes but not the overall quantity of reflux epi-
sodes.55 In cats, esophageal pH during anesthesia could be significantly increased
when 2 oral doses of omeprazole were given 18 to 24 and 4 hours before anesthesia,
and no reflux episodes (defined as a pH of <4) were recorded during anesthesia
compared with placebo-treated cats.56
The same principle of increasing the LES pressure together with gastric acid sup-
pression to prevent further injury and allow esophageal healing has been recommen-
ded in the treatment of suspected reflux esophagitis. In cats, experimentally induced
esophagitis decreases esophageal peristalsis, decreases the LES pressure, and di-
minishes esophageal clearance.3 These changes were reversible with healing of the
esophagus.3 Contradictory to common belief, orally administered metoclopramide
administration did not result in significant changes in the LES pressure in dogs.
Only cisapride administration significantly increased LES pressure in a placebo-
controlled study.57 A mainstay of treatment for suspected esophagitis is a combina-
tion of gastric acid suppression and sucralfate. In dogs and cats, proton pump inhib-
itors (ie, omeprazole) provide superior gastric acid suppression compared with H2
receptor antagonists (ranitidine, famotidine) and should therefore be considered
more effective for the treatment of acid-related disorders.58
Twice daily dosing (1–1.5 mg/kg) is advised to maximize gastric acid suppression in
canine and feline esophagitis. An exception may be esomeprazole in dogs, because
once-daily oral dosing in a recent study also lead to an adequate increase of intragas-
tric pH.59 Sucralfate, an aluminum salt of a sulfated disaccharide, is a mucosal protec-
tant that binds to inflamed tissue to create a protective barrier. It is supposed to block
diffusion of gastric acid and pepsin across the esophageal mucosa and inhibit the
erosive action of pepsin and possibly bile.58 Although the rationale for its effectiveness
is based on its protective adherence to denuded mucosal surface in an acidic environ-
ment, and the canine esophageal milieu is weakly alkaline,28 clinically it seems to
soothe the patient’s discomfort when dosedmultiple times daily.58 In people, intensive
high-dose sucralfate therapy (2 g of sucralfate given orally every 2 hours for the first
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3 days, followed by 2 g 8 times daily for 21 days) has been shown to be beneficial in
enhancing mucosal healing and preventing stricture formation in advanced-grade cor-
rosive esophagitis.60 EE has been successfully treated with dietary antigen elimination
(ie, hydrolyzed diet) in a cat and with corticosteroids in a dog.24,25 When present, stric-
tures may need esophageal bougienage or balloon dilation. Budesonide orodispersi-
ble tablets have recently been shown to be a promising new option for the induction of
clinical and histologic remission in a placebo-controlled trial in humans with EE.61 Life-
style changes are part of the initial management of reflux esophagitis in people and
include losing weight if overweight, avoiding bed time snacks, and elevating the
head at night. Although this therapy intuitively makes sense, no data are available
on this strategy in small animals.
SUMMARY
Esophagitis in cats and dogs is largely a consequence of prolonged esophageal expo-
sure to acid, which in turn can have various underlying causes. Analogous to GERD in
humans, an incompetent LES is also often suspected to cause clinical signs, but the
validity of these clinical signs remains currently unclear. The diagnosis can be
confirmed endoscopically, with esophageal biopsies, with esophageal wireless pH
monitoring or through a clear response to therapeutic trials with sufficiently dosed pro-
ton pump inhibitors. In unclear cases that do not respond satisfyingly to treatment,
chronic enteropathy should be suspected and strict dietary trials should be tried out.
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